Book NOW for a unique
and exclusive experience
Contact us
MRNA Injection - Attention
Please be advised that to ensure the safety of our staff and clients that Bell Hill Retreat will not be accepting clients who have taken the experimental unlicensed MRNA Covid injection within 30 days of their appointment.
This decision is based on the fact that the manufacturers have not accepted any financial liability for compensating any adverse events of their MRNA Covid injections, in fact in New Zealand they have been granted indemnity by the government. In New Zealand the injection has only been given provisional approval by MedSafe with 58 provisions, many of which do not have to be met until July 2021. Furthermore we have taken into account the lack of animal trials (especially long term safety studies), lack of long-term human trials and a lack of comprehensive trials which include a true representation of the population (not just the healthy) as well as lack of reporting the effects of the injection on human reproduction. Many of these concerns are shared by MedSafe in their Summery of Risk Management for the Covid injection. We are also aware of past animal trials in 2012 with MDNA injection technology where animals suffered from pulmonary immunopathology on challenge with the SARS virus. Finally, we are considering worldwide vaccine adverse reaction reporting systems such as this one which according to this government report (page 6, third paragraph) only represent 1% of the actual numbers and yet already show alarming rates of adverse reactions.
The purpose of this policy is to protect our practitioners from possible spike protein viral shedding and overall transmission from injected persons to non injected persons according to this Pfizer document (bottom of page 67) and also to prevent possible contraindications of our treatments with the possible negative side effects of the experimental injection. Reported side effects that concern us include and are not limited to; flu symptoms, miscarriages, still births, infertility, seizures, blood clotting disorders, autoimmune disorders, neurological damage, prion disease, encephalitis, brain damage, Bell's Palsy and death.
We apologize for any inconvenience and we will re-evaluate our policy when clinical trials of the experimental injection are completed in 2023 (see Pfizer study with beginning date April 29th, 2020 to completion date April 6th, 2023) or when new information comes to light.
Thank you for your understanding.
Open VAERS Database
Open Letter Signed by 40 NZ Doctors
Summary of the risk management plan for Comirnaty (COVID-19 mRNA vaccine) by MedSafe
58 Conditions of Provisional Medsafe Approval in NZ
Vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease study
COVID-19 RNA Based Vaccines and the Risk of Prion Disease Study
Assessment of risk of disease enhancement with COVID-19 vaccines study
Pfizer Document Viral Shedding (bottom of page 67)
Dr. Ryan Cole, comprehensive talk on Covid
This decision is based on the fact that the manufacturers have not accepted any financial liability for compensating any adverse events of their MRNA Covid injections, in fact in New Zealand they have been granted indemnity by the government. In New Zealand the injection has only been given provisional approval by MedSafe with 58 provisions, many of which do not have to be met until July 2021. Furthermore we have taken into account the lack of animal trials (especially long term safety studies), lack of long-term human trials and a lack of comprehensive trials which include a true representation of the population (not just the healthy) as well as lack of reporting the effects of the injection on human reproduction. Many of these concerns are shared by MedSafe in their Summery of Risk Management for the Covid injection. We are also aware of past animal trials in 2012 with MDNA injection technology where animals suffered from pulmonary immunopathology on challenge with the SARS virus. Finally, we are considering worldwide vaccine adverse reaction reporting systems such as this one which according to this government report (page 6, third paragraph) only represent 1% of the actual numbers and yet already show alarming rates of adverse reactions.
The purpose of this policy is to protect our practitioners from possible spike protein viral shedding and overall transmission from injected persons to non injected persons according to this Pfizer document (bottom of page 67) and also to prevent possible contraindications of our treatments with the possible negative side effects of the experimental injection. Reported side effects that concern us include and are not limited to; flu symptoms, miscarriages, still births, infertility, seizures, blood clotting disorders, autoimmune disorders, neurological damage, prion disease, encephalitis, brain damage, Bell's Palsy and death.
We apologize for any inconvenience and we will re-evaluate our policy when clinical trials of the experimental injection are completed in 2023 (see Pfizer study with beginning date April 29th, 2020 to completion date April 6th, 2023) or when new information comes to light.
Thank you for your understanding.
Open VAERS Database
Open Letter Signed by 40 NZ Doctors
Summary of the risk management plan for Comirnaty (COVID-19 mRNA vaccine) by MedSafe
58 Conditions of Provisional Medsafe Approval in NZ
Vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease study
COVID-19 RNA Based Vaccines and the Risk of Prion Disease Study
Assessment of risk of disease enhancement with COVID-19 vaccines study
Pfizer Document Viral Shedding (bottom of page 67)
Dr. Ryan Cole, comprehensive talk on Covid
Each of our units are modelled on historical cottages from the early 1900s and named after local identities from the gold mining and timber era of the time.
View our facilities >
© Bell Hill Retreat Ltd - Bed and Breakfast
Site powered by Concilio Agency